Physician profile
Mark Bradford
NPI 1548335938
$3,629.68
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $827 · 2020: $1,452 · 2021: $1,130 · 2022: $221.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $702.09 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $568.00 | 2019-2022 | |
| Novo Nordisk INC | $509.77 | 2019-2022 | |
| Dexcom, INC. | $363.33 | 2020-2022 | |
| Lilly USA, LLC | $351.81 | 2019-2021 | |
| Abbvie INC. | $342.21 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $211.19 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.65 | 2019-2021 | |
| Insulet Corporation | $74.14 | 2019 | |
| Abbott Laboratories | $45.18 | 2019-2020 | |
| Radius Health, INC. | $43.16 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $42.88 | 2019-2020 | |
| Amgen INC. | $42.16 | 2019-2020 | |
| Lifescan, INC. | $36.65 | 2020 | |
| Ascensia Diabetes Care US INC. | $35.89 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $25.39 | 2019-2020 | |
| Antares Pharma, INC. | $17.42 | 2022 | |
| Amarin Pharma, INC. | $16.40 | 2021 | |
| Zealand Pharma US, INC. | $14.32 | 2021 | |
| Companion Medical, INC. | $12.68 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.36 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bradford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.